160P Predicting Immune-Related Adverse Events Using Biomarkers in Early-Phase Cancer Immunotherapy Trials

B.P. Fairfax, V.C. Schmid, D.F. Lamparter, T. Kam-Thong, P. Scepanovic, G. Duchateau-Nguyen,A. Roller,R. Mohindra,V. Karanikas,D. Heinzmann, C. Adams, S.L. Mycroft, N. Städler

Annals of Oncology（2024）

Cited 0|Views4

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined